- Erratum: Penumbral Imaging-Based Thrombolysis with Tenecteplase Is Feasible up to 24 Hours after Symptom Onset
-
Kate M, Wannamaker R, Kamble H, Riaz P, Gioia LC, Buck B, Jeerakathil T, Smyth P, Shuaib A, Emery D, Butcher K
- KMID: 2428779
- J Stroke.
- 2018 Sep;20(3):415-415.
- doi: 10.5853/jos.2017.00178.e1
There is a mistake of last two authors' order. -
- CITED
-
- Close
- SHARE
-
- Close
- Collateral Circulation in Ischemic Stroke: An Updated Review
-
Maguida G, Shuaib A
- KMID: 2542470
- J Stroke.
- 2023 May;25(2):179-198.
- doi: 10.5853/jos.2022.02936
The collateral circulation plays a crucial role in maintaining perfusion to brain tissue in ischemic stroke, which prolongs the time window for effective therapies to be provided and ultimately avoids... -
- CITED
-
- Close
- SHARE
-
- Close
- Penumbral Imaging-Based Thrombolysis with Tenecteplase Is Feasible up to 24 Hours after Symptom Onset
-
Kate M, Wannamaker R, Kamble H, Riaz P, Gioia LC, Buck B, Jeerakathil T, Smyth P, Shuaib A, Butcher K, Emery D
- KMID: 2424443
- J Stroke.
- 2018 Jan;20(1):122-130.
- doi: 10.5853/jos.2017.00178
BACKGROUND AND PURPOSE: Thrombolysis >4.5 hours after ischemic stroke onset is unproven. We assessed the feasibility of tenecteplase (TNK) treatment in patients with evidence of an ischemic penumbra 4.5 to... -
- CITED
-
- Close
- SHARE
-
- Close
- Trends in Stroke Presentations before and during the COVID-19 Pandemic: A Meta-Analysis
-
Ishaque N, Butt AJ, Kamtchum-Tatuene J, Nomani AZ, Razzaq S, Fatima N, Vekhande C, Nair R, Akhtar N, Khan K, Saqqur M, Shuaib A
- KMID: 2525332
- J Stroke.
- 2022 Jan;24(1):65-78.
- doi: 10.5853/jos.2021.01571
Background and Purpose There are reports of decline in the rates of acute emergency presentations during coronavirus disease 2019 (COVID-19) pandemic including stroke. We performed a meta-analysis of the impact... -
- CITED
-
- Close
- SHARE
-
- Close
- Timing of Recanalization and Functional Recovery in Acute Ischemic Stroke
-
Tsivgoulis G, Saqqur M, Sharma VK, Brunser A, Eggers J, Mikulik R, Katsanos A, Sergentanis TN, Vadikolias K, Perren F, Rubiera M, Bavarsad Shahripour R, Nguyen HT, Martínez-Sánchez P, Safouris A, Heliopoulos I, Shuaib A, Derksen C, Voumvourakis K, Psaltopoulou T, Alexandrov AW, Alexandrov AV, CLOTBUST-PRO investigators
- KMID: 2500925
- J Stroke.
- 2020 Jan;22(1):130-140.
- doi: 10.5853/jos.2019.01648
Background and Purpose Although onset-to-treatment time is associated with early clinical recovery in acute ischemic stroke (AIS) patients treated with intravenous tissue plasminogen activator (tPA), the effect of the timing... -
- CITED
-
- Close
- SHARE
-
- Close
